Great interest for Oasmia in Budapest
September 20 2007
Great interests for Oasmia in Budapest
Last week Oasmia Pharmaceutical AB presented the results from a phase I/II study with Paclical® Vet at the Veterinary European ECVIM-CA Congress in Budapest.
- The information about Oasmias new product has through the congress reached a greater public. Several leading veterinary clinics in Europe look forward to see Paclical® Vet on the market. There is a huge need of the product, says Kristina Fritjofsson, Head of Clinical Development at Oasmia.
The press release is available in PDF-format here.
